Zomepirac: an overview--concluding remarks of the symposium chairman.
D000700:Analgesics / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D002908:Chronic Disease; D006801:Humans; D007700:Kinetics; D009369:Neoplasms / Q000150:complications; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D011758:Pyrroles / Q000494:pharmacology*; D013997:Time Factors; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use
D000700:Analgesics; D011758:Pyrroles; C020549:zomepirac; D014046:Tolmetin; D001241:Aspirin